$VYGR SEC Filings

Filed On	Filing
21 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This Amended and Restated Employment Agreement (this “Agreement”) is made as of October 20, 2026 (the “Effective Date”) by and between Voyager Therapeutics, Inc. (the “Company”) and Robin Swartz (the “Executive”).
14 Aug 2026	SCHEDULE 13G/A
06 Aug 2026	10-Q
06 Aug 2026	8-K: Results of Operations and Financial Condition
31 Jul 2026	SCHEDULE 13G/A
13 Jul 2026	8-K: Other Events
11 Jun 2026	Form 4: Scangos George A, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Mackey Catherine J, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Hyman Steven, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Vitale Nancy, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Higgins Michael J, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Onyia Jude, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Geraghty James A, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Colon Grace, Director Granted 30,000 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Pierce Glenn, Director Granted 30,000 Stock Option (Right to Buy)
10 Jun 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
01 Jun 2026	8-K: Other Events
18 May 2026	Form 3: Quinlan Amy, Principal Accounting Officer Holds 36,749 shares of Common Stock
15 May 2026	144
15 May 2026	SCHEDULE 13G/A

Comments